VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $486,000 | -44.3% | 12,674 | -52.8% | 0.30% | -33.5% |
| Q1 2021 | $873,000 | -70.5% | 26,847 | -67.3% | 0.45% | -71.2% |
| Q4 2020 | $2,961,000 | -28.0% | 82,206 | -21.8% | 1.56% | -37.8% |
| Q3 2020 | $4,114,000 | +27.5% | 105,062 | +19.5% | 2.52% | +11.2% |
| Q2 2020 | $3,226,000 | +335.9% | 87,943 | +173.6% | 2.26% | +115.0% |
| Q1 2020 | $740,000 | -47.3% | 32,138 | -33.0% | 1.05% | +8.6% |
| Q4 2019 | $1,404,000 | -2.7% | 47,958 | -11.2% | 0.97% | -13.7% |
| Q3 2019 | $1,443,000 | +450.8% | 54,033 | +427.8% | 1.12% | +429.7% |
| Q2 2019 | $262,000 | +11.5% | 10,237 | -2.4% | 0.21% | +6.0% |
| Q1 2019 | $235,000 | – | 10,487 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |